Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus.

Cancer gene therapy - 1 Dec 2010

Ahmed M, Puckett S, Lyles D S

Abstract excerpt

Matrix (M) protein mutants of vesicular stomatitis virus (VSV), such as rM51R-M virus, are attractive candidates as oncolytic viruses for tumor therapies because of their capacity to selectively target cancer cells. The effectiveness of rM51R-M virus as an antitumor agent for the treatment of breast cancer was assessed by determining the ability of rM51R-M virus to infect and kill breast cancer cells in vitro and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cell Line, Tumor
Share to Interleukin-12

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutant Proteins

Share to Oncolytic Virotherapy

Share to Oncolytic Viruses

Share to Viral Matrix Proteins

Share to Virus Replication

Source

Open in PubMed Open full text

Identifiers

PMID: 20725101
DOI: 10.1038/cgt.2010.46
PMCID: PMC3682428

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus.PMID 20725101Read ↗

Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice.Semantic proximity Read ↗

Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus.Semantic proximity Read ↗

Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.Semantic proximity Read ↗

Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo.Semantic proximity Read ↗

Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways.Semantic proximity Read ↗

Matrix Protein and Another Viral Component Contribute to Induction of Apoptosis in Cells Infected with Vesicular Stomatitis VirusSemantic proximity Read ↗

Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.Semantic proximity Read ↗

Rapid Pathogenesis Induced by a Vesicular Stomatitis Virus Matrix Protein Mutant: Viral Pathogenesis Is Linked to Induction of Tumor Necrosis Factor AlphaSemantic proximity Read ↗

Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.